Controversias en la Investigación Clínica. Estudios específicos de Raza y el caso BIDIL

• Fernández Pinto, Manuela ^[1]
  1. [1] Universidad de Los Andes

     Universidad de Los Andes

     Colombia

     
• Localización: Ideas y valores: Revista Colombiana de Filosofía, ISSN-e 0120-0062, Vol. 71, Nº. Extra 8, 2022 (Ejemplar dedicado a: Controversias científicas), págs. 218-236
• Idioma: español
• DOI: 10.15446/ideasyvalores.v71n8Supl.103586
• Títulos paralelos:
  • Controversies in Clinical Research. Race-Specific Studies and the BiDil Case
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    El objetivo principal de este artículo es analizar los estudios que respaldan la aprobación y el uso del BiDil, el primer medicamento aprobado para uso exclusivo en población afroamericana en EE. UU., así como la controversia que surgió alrededor de este. En particular, mostraré que la controversia sobre el BiDil no debe entenderse como una controversia puramente epistémica, sino como una controversia compleja en la que convergen aspectos tanto epistémicos como ético-sociales y comerciales. Entender cómo están interrelacionados estos aspectos y qué conocimiento podemos obtener dada la complejidad de estas interacciones resulta crucial para comprender la controversia sobre el BiDil, así como otras controversias científicas actuales.

  • English

    This article aims to analyze the clinical studies that support the approval and use of BiDil, the first drug approved for exclusive use in African-Americans, as well as the controversy surrounding this drug. In particular, my aim is to show that the controversy over BiDil should not be understood as purely epistemic, but rather as a complex controversy in which epistemic, ethical, and commercial aspects converge. Understanding how these aspects are interrelated and what knowledge is available to us given the complexity of such interrelations is crucial for understanding the BiDil controversy, as well as other scientific controversies today.

• Referencias bibliográficas
  • Allchin, Douglas. “Values in Science: An Educational Perspective.” Science & Education 8 (1999): 1-12. [https://doi.org/10.1023/A:1008600230536]
  • Anderson, Elizabeth. “Uses of Value Judgments in Science: A General Argument, with Lessons from a Case Study of Feminist Research on Divorce.”...
  • Ball, Catherine et al. “Genetic Communities™ White Paper: Predicting fine-scale ancestral origins from the genetic sharing patterns among...
  • Bigos, Kristin L., Bruce Pollock, Beth Stankevich, Rober Bies. “Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants:...
  • Bloche, M. Gregg. “Race-Based Therapeutics.” The New England Journal of Medicine 351.20 (2004): 2035-37.
  • Broadbent, Alex. “Inferring Causation in Epidemiology: Mechanisms, Black Boxes, and Contrasts. Causality in the Sciences. Edited by Illari...
  • Brown, Matthew. “Values in Science beyond Underdetermination and Inductive Risk.” Philosophy of Science 80.5 (2013): 829-839.
  • Carson, Peter et al. “Racial Differences in Response to Therapy for Heart Failure: Analysis of the Vasodilator-Heart Failure Trials.” Journal...
  • Cruickshank, J K, and D G Beevers. “Epidemiology of hypertension: blood pressure in blacks and whites.” 62.1 (1982): 1-6. [https://doi.org/10.1042/cs0620001]
  • De Melo-Martín, Inmaculada and Intemann, Kristen. The Fight Against Doubt: How to Bridge the Gap Between Scientists and the Public. Oxford...
  • Dirks, N L et al. “Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.” International journal of clinical pharmacology...
  • Douglas, Heather E. Science, Policy, and the Value-Free Ideal. University of Pittsburgh, 2009.
  • Dries, Daniel L. et al. “Racial Differences in the Outcome of Left Ventricular Dysfunction.” New England Journal of Medicine 340. 8 (1999):...
  • Epstein, Steven. Inclusion: The Politics of Difference in Medical Research. The University of Chicago Press, 2007.
  • Fernández Pinto, Manuela. “Democratizing Strategies for Industry-Funded Medical Research: A Cautionary Tale.” Philosophy of Science 85.5 (2018):...
  • Fernández Pinto, Manuela. “Philosophy of Science for Globalized Privatization. Uncovering Some Limitations of Critical Contextual Empiricism.”...
  • Franciosa, Joseph A. et al. “African-American Heart Failure Trial (a-heft): Rationale, Design, and Methodology.” Journal of Cardiac Failure...
  • Frohlich, Edward D. “Left ventricular hypertrophy: a major factor of risk in Black hypertensive patients.” American journal of hypertension...
  • Fuentes, Agustín. Race, Monogamy, and Other Lies They Told You. University of California Press, 2012.
  • Grasswick, Heidi. E. “Feminist Epistemology and Philosophy of Science.” Feminist Philosophy Collection, 2011. [https://doi.org/10.1007/978-1-4020-6835-5]
  • Hempel, Carl. Aspects of Scientific Explanation. Free Press, 1965.
  • Henig, Robin Marantz. “The Genome in Black and White (and Gray).” New York Times (1923-Current File), 2004. sm46, [http://proquest.umi.com/pqdweb?did=107166399...
  • Holman, Bennett y Kevin C. Elliott. “The Promise and Perils of Industry-Funded Science.” Philosophy Compass 13.11 (2018): 1-14. [https://doi.org/10.1111/phc3.12544]
  • Howard, George et al. “Racial and Geographic Differences in Awareness, Treatment, and Control of Hypertension.” Stroke 37.5 (2006): 1171-1178....
  • Kahn, Jonathan. “How a Drug Becomes Ethnic: Law, Commerce, and the Production of Racial Categories in Medicine.” Yale Journal of Health Policy,...
  • Krieger, Nancy et al. “Racism, sexism, and social class: implications for studies of health, disease, and well-being.” American Journal of...
  • Kuhn, Thomas. The Essential Tension. The University of Chicago Press, 1977.
  • Longino, Helen E. “Gender, Politics, and the Theoretical Virtues.” Synthese 104.3 (1995): 383-397. [https://doi.org/10.1007/BF01064506]
  • McMullin, Ernan. “Scientific Controversy and Its Termination.” Scientific Controversies: Case Studies in the Resolution and Closure of Disputes...
  • Moser, Marvin and Lunn, Jhon. “Responses to captopril and hydrochlorothiazide in black patients with hypertension.” Clinical pharmacology...
  • Neurath, Otto. “The Lost Wanderers of Descartes and the Auxiliary Motive.” Philosophical Papers 1913-1946. 2011. 1-12. [https://doi.org/10.1007/978-94-009-6995-7_1]
  • Pollock, Anne. Medicating Race. Duke University Press, 2012. [https://doi.org/10.1215/ 9780822395782]
  • Ramasubbu, Kumudha; Gurm, Hitinder, and Litaker, David.“Gender Bias in Clinical Trials: Do Double Standards Still Apply?” Journal of Women’s...
  • Rosenberg, Noah A et al. “Genetic structure of human populations.” Science 298.5602 (2002): 2381-5. [https://doi.org/10.1038/s41598-020-80389-9]
  • Rudner, Richard. “The Scientist qua Scientist Makes Value Judgments.” Philosophy of Science 20.1 (1953): 1-6. [https://psycnet.apa.org/doi/10.1086/287231]
  • Schwartz, Robert. “Racial Profiling in Medical Research.” New England Journal of Medicine 344.18 (2001): 1392-93.
  • Sismondo, Sergio. Ghost-Managed Medicine: Big Pharma’s Invisible Hands. Mattering Press, 2018.
  • Solomon, Miriam. Social Empiricism. Massachusetts Institute of Technology Press, 2001.
  • Taylor, Anne L. et al. “Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure.” New England Journal of Medicine...
  • Taylor, Holly A. “Inclusion of women, minorities, and children in clinical trials: opinions of research ethics board administrators.” Journal...
  • Tseng, Jennifer E., et al. “Advances in Brief Gender Differences in P53 Mutational Status in Small Cell Lung Cancer 1.” Lung Cancer. 1999....
  • Valles, Sean A. “Heterogeneity of Risk within Racial Groups, a Challenge for Public Health Programs.” Preventive Medicine 55.5 (2012): 405-408....